ICCB280
ICCB280 was capable of inducing differentiation and apoptosis of ATRA-resistant patient blasts strongly signify that the activity of this compound can overcome resistance to other current therapies for AML with an unfavorable prognosis.
Product Specifications
CAS Number
2041072-41-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
386.4
Molecular Formula
C23H18N2O4
Notes
Research use only, not for human use.
Receptor
C/EBPα
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
NC026-01 50 µg
Human CD19xCD3 Antibody (Blinatumomab, Research Grade)
Sign In for Pricing
View Details NC026-02 1 mg
Human CD19xCD3 Antibody (Blinatumomab, Research Grade)
Sign In for Pricing
View Details 
11343-05061 5x 30 µg
Mouse Fibronectin (FN) AssayLite™ Antibody (APC Conjugate)
Sign In for Pricing
View Details